
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services is supported by a favorable mix of scale, higher-margin behavioral health, and improving operating momentum, with behavioral health generating just over half of consolidated operating income despite acute care contributing over 55% of revenue. The company’s 1Q26 adj. EBITDA rose 8.4% year over year, helped by pricing strength, higher acuity mix, and behavioral health SS revenue up 7.3%, while management expects volume to improve as seasonal headwinds fade and new capacity ramps. Its outlook is further strengthened by continued market share gains in attractive acute-care markets, a persistent multi-year State Directed Payment tailwind, and a disciplined capital plan including $800-900m of share repurchases and earnings-accretive expansion into outpatient care.
Bears say
Universal Health Services is pressured by a difficult mix of regulatory, labor, and market-concentration risks that could undermine both volume and margins, especially if Medicare-for-All, Affordable Care Act changes, or CMS payment actions reduce reimbursement. Its behavioral health business, which generates over 55% of pretax profits, is particularly exposed to tight state budgets, while acute care still represents over 55% of revenue and faces weaker core growth, with 1Q26 acute volumes flat and HIX volumes down 5%. The company also carries headline and operational risk from its September 2020 cyberattack, estimated to have cost $67MM pre-tax, and its heavy concentration in Nevada, Texas, and California leaves results vulnerable to localized weakness.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares